☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Solid Biosciences
Solid Biosciences Signed an Exclusive License Agreement with Armatus Bio for AAV-SLB101 in Facioscapulohumeral Muscular Dystrophy...
March 8, 2024
Solid Biosciences Entered into a Research Collaboration with Phlox Therapeutics to Develop New Therapies for Rare Cardiac Diseases
January 12, 2023
Solid Biosciences to Acquire AavantiBio for Gene Therapy Programs
October 3, 2022
Load more...
Back to Home
Modal title
×
Modal body text goes here.